1
|
Gramage Caro T, Palomar Fernández C, Pueyo López C, Sánchez Cuervo M, Gómez de Salazar López de Silanes M, Bermejo Vicedo T. Validación de una clasificación de errores de medicación para su utilización en quimioterapia. FARMACIA HOSPITALARIA 2011; 35:197-203. [DOI: 10.1016/j.farma.2010.04.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2010] [Revised: 04/23/2010] [Accepted: 04/28/2010] [Indexed: 10/19/2022] Open
|
2
|
Serrano-Fabiá A, Albert-Marí A, Almenar-Cubells D, Víctor Jiménez-Torres N. Multidisciplinary system for detecting medication errors in antineoplastic chemotherapy. J Oncol Pharm Pract 2009; 16:105-12. [DOI: 10.1177/1078155209340482] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Objective. To analyze medication errors (MEs) in a multidisciplinary system with a Computerized Pharmacotherapy Process (CPP) in cancer patients. Design. A longitudinal, prospective 2-year (January 2003 —to December 2004) cohort study was made in adult patients administered antineoplastic treatment in Services of Oncology and Haematology. MEs were identified by double cross-validation of each stage of the pharmacotherapeutic process (prescription, preparation, dispensing, administration, and follow-up) carried out by the multidisciplinary team (physician, pharmacist, nurse) with CPP assistance. Variables. Number of MEs per 1000 patient-days, percentage according to the stage of the pharmacotherapeutic process and the severity of intercepted ME (scored from 1 = no damage to the patient, to 5 = patient death). Results. A total of 1311 patients were receiving treatment, and MEs were identified in 225. Out of a total of 13,158 patient-days, 276 MEs were detected, equivalent to 20.9 MEs per 1000 patient-days; of these, 16.8 MEs per 1000 patient-days (80%) were intercepted and did not affect any patient. The detected ME distribution according to pharmacotherapeutic stage was: prescription 75.7%, preparation 21.0%, dispensing 1.8%, administration 1.1%, and follow-up 0.4%. ME distribution according to severity was: grade 1 : 15.9%, grade 2 : 49.6%, grade 3 : 33.7%, grade 4 : 0.7%, and grade 5 : 0%. The system intercepted 98.9% of all MEs with severity ≥3 (MEs with a potential for causing patient damage). Conclusions. The multidisciplinary system with a well-established CPP detects 20.9 MEs per 1000 patient-days and intercepts 98.8% of all MEs with a potential for causing patient damage. J Oncol Pharm Practice (2010) 16: 105—112.
Collapse
Affiliation(s)
| | - Asunción Albert-Marí
- Pharmacy Deparment, Hospital Dr. Peset, Valencia, Spain, Pharmacy and Pharmaceutical Technology Deparment. University of Valencia, Spain
| | | | - N. Víctor Jiménez-Torres
- Pharmacy Deparment, Hospital Manacor, Baleares, Spain, Pharmacy and Pharmaceutical Technology Deparment. University of Valencia, Spain
| |
Collapse
|
3
|
Garzás-Martín de Almagro M, López-Malo de Molina M, Abellón Ruiz J, Fernández García I, Isla Tejera B. Validación farmacéutica y detección de errores de prescripción de antineoplásicos en pacientes oncohematológicos. FARMACIA HOSPITALARIA 2008. [DOI: 10.1016/s1130-6343(08)75948-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
4
|
Díaz-Carrasco M, Pareja A, Yachachi A, Cortés F, Espuny A. Errores de prescripción en quimioterapia. FARMACIA HOSPITALARIA 2007; 31:161-4. [DOI: 10.1016/s1130-6343(07)75364-3] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|